Tiziana Life Sciences Advances with Promising Drug Trials [Yahoo! Finance]
Tiziana Life Sciences Ltd - Common Shares (TLSA)
Company Research
Source: Yahoo! Finance
Tiziana Life Sciences has reported promising progress in its lead programs targeting neurodegenerative and autoimmune diseases, particularly with its drug Foralumab. Encouraging interim results show potential for this drug to offer more effective and less harmful treatments for conditions like multiple sclerosis, with a Phase 2 study underway and FDA Fast Track designation granted. These developments highlight Tiziana's commitment to innovative therapies that could significantly impact patient care. For further insights into TLSA stock, check out TipRanks' Recommended Stories
Show less
Read more
Impact Snapshot
Event Time:
TLSA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLSA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLSA alerts
High impacting Tiziana Life Sciences Ltd - Common Shares news events
Weekly update
A roundup of the hottest topics
TLSA
News
- Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association [Yahoo! Finance]Yahoo! Finance
- Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS AssociationGlobeNewswire
- Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study DataGlobeNewswire
- Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million [Yahoo! Finance]Yahoo! Finance
- Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 MillionGlobeNewswire
TLSA
Sec Filings
- 11/19/24 - Form 6-K
- 11/1/24 - Form 6-K
- 11/1/24 - Form 424B5
- TLSA's page on the SEC website